| Literature DB >> 29538503 |
Simone de Campos Neitzke Winter1, Rafael Michel de Macedo1, Júlio Cesar Francisco1, Paula Costa Santos1, Ana Paula Sarraff Lopes1, Leanderson Franco de Meira1, Katherine A Teixeira de Carvalho2, José Rocha Faria Neto1, Ana Carolina Brandt de Macedo3, Luiz César Guarita-Souza1.
Abstract
BACKGROUND: Physical exercise should be part of the treatment of post-acute myocardial infarction (AMI) patients.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29538503 PMCID: PMC5941962 DOI: 10.5935/abc.20180036
Source DB: PubMed Journal: Arq Bras Cardiol ISSN: 0066-782X Impact factor: 2.000
Within-group echocardiographic comparison of mean left ventricular ejection fraction, end-diastolic diameter and end-systolic diameter
| GROUP | EDD1 | EDD2 | p | ESD1 | ESD2 | p | LVEF1 | LVEF2 | p |
|---|---|---|---|---|---|---|---|---|---|
| CG | 0.26 | 0.13 | 0.008 | 0.17 | 0.74 | 0.120 | 76.10 | 71.20 | 0.112 |
| CTG | 0.50 | 0.58 | 0.741 | 0.83 | 0.19 | 0.422 | 73.67 | 71.89 | 0.579 |
| ITG | 0.19 | 0.88 | 0.153 | 0.78 | 0.01 | 0.510 | 70.70 | 71.50 | 0.792 |
CG: control group, CTG: continuous training group; ITG: interval training group; EDD1: end-diastolic diameter at first evaluation; EDD2: end-diastolic diameter at the second evaluation; ESD1: end-systolic diameter at first evaluation; ESD2: end-systolic diameter at second evaluation; LVEF1: left ventricular ejection fraction at first evaluation; LVEF2: left ventricular ejection fraction at second evaluation; p = p-value of LVEF between the two study days. Student's t-test,
p < 0.05.
Between-group echocardiographic comparisons of left ventricular ejection fraction, end-diastolic diameter and end-systolic diameter
| Variable | Group | Mean ± SD | p |
|---|---|---|---|
| LVEF1 (%) | CG | 76.10 ± 6.89 | 0.368 |
| CTG | 73.67 ± 10.01 | ||
| ITG | 70.70 ± 8.15 | ||
| LVEF 2 (%) | CG | 71.20 ± 6.44 | 0.981 |
| CTG | 71.89 ± 8.68 | ||
| ITG | 71.50 ± 7.53 | ||
| EDD 1 (mm) | CG | 5.26 ± 0.80 | 0.103 |
| CTG | 6.50 ± 1.63 | ||
| ITG | 6.19 ± 1.30 | ||
| EDD2 (mm) | CG | 6.20 ± 0.58 | 0.404 |
| CTG | 6.00 ± 1.15 | ||
| ITG | 6.00 ± 1.69 | ||
| ESD1 (mm) | CG | 3.17 ± 0.70 | 0.308 |
| CTG | 3.83 ± 0.93 | ||
| ITG | 3.78 ± 1.40 | ||
| ESD 2 (mm) | CG | 3.74 ± 0.75 | 0.709 |
| CTG | 4.19 ± 1.23 | ||
| ITG | 4.01 ± 1.46 |
LVEF1: left ventricular ejection fraction at first evaluation; LVEF2: left ventricular ejection fraction at second evaluation; p: p-value of LVEF between the two study days EDD1: end-diastolic diameter at first evaluation; EDD2: end-diastolic diameter at the second evaluation; ESD1: end-systolic diameter at first evaluation; ESD2: end‑systolic diameter at second evaluation; CG: control group, CTG: continuous training group; ITG: interval training group; One-factor ANOVA
Within-group comparisons of pre- and post-training lactate test parameters
| Variables | Group | N | Mean T1 (SD) | Mean T2 (SD) | p |
|---|---|---|---|---|---|
| LR | CG | 10 | 3.90 ± 1.07 | 4.32 ± 0.47 | 0.240 |
| CTG | 9 | 3.83 ± 0.96 | 3.96 ± 0.22 | 0.720 | |
| ITG | 10 | 4.18 ± 0.81 | 4.24 ± 0.32 | 0.830 | |
| LO | CG | 10 | 5.92 ± 1.11 | 5.99 ± 0.74 | 0.850 |
| CTG | 9 | 5.90 ± 2.26 | 5.07 ± 0.88 | 0.392 | |
| ITG | 10 | 5.96 ± 1.04 | 5.18 ± 0.47 | 0.084 | |
| L12g | CG | 10 | 6.58 ± 1.16 | 6.76 ± 1.04 | 0.735 |
| CTG | 9 | 7.32 ± 1.83 | 5.66 ± 1.06 | 0.062 | |
| ITG | 10 | 8.08 ± 1.56 | 5.82 ± 0.65 | 0.002 | |
| L13.5g | CG | 10 | 6.80 ± 1.32 | 6.52 ± 1.80 | 0.733 |
| CTG | 9 | 8.11 ± 2.14 | 5.67 ± 0.92 | 0.014 | |
| ITG | 10 | 8.40 ± 2.28 | 5.97 ± 0.80 | 0.032 |
CG: control group, CTG: continuous training group; ITG: interval training group; SD: standard deviation; LR: lactate at rest; LO: lactate without overload; L12g: lactate with 12 grams of additional load; L13.5g: lactate with 13.5 grams of additional load. Student's t test.
p < 0.05.
Between-group comparison of lactate test parameters
| Variable | Group | n | Mean ± SD | p-value |
|---|---|---|---|---|
| LWO 1 | CG | 10 | 5.92 ± 1.11 | 0.996 |
| CTG | 9 | 5.90 ± 2.26 | ||
| ITG | 10 | 5.96 ± 1.04 | ||
| LWO 2 | CG | 10 | 5.99 ± 0.74 | 0.016 |
| CTG | 9 | 5.07 ± 0.88 | ||
| ITG | 10 | 5.18 ± 0.47 | ||
| L 12 g 1 | CG | 10 | 6.58 ± 1.16 | 0.110 |
| CTG | 9 | 7.32 ± 1.83 | ||
| ITG | 10 | 8.08 ± 1.56 | ||
| L 12g 2 | CG | 10 | 6.76 ± 1.04 | 0.031 |
| CTG | 9 | 5.66 ± 1.06 | ||
| ITG | 10 | 5.82 ± 0.65 | ||
| L 13.5g 1 | CG | 10 | 6.80 ± 1.32 | 0.176 |
| CTG | 9 | 8.11 ± 2.14 | ||
| ITG | 10 | 8.40 ± 2.28 | ||
| L 13.5 g 2 | CG | 10 | 6.52 ± 1.80 | 0.341 |
| CTG | 9 | 5.67 ± 0.92 | ||
| ITG | 10 | 5.97 ± 0.80 |
CG: control group; CTG: continuous training group; ITG:interval training group; SD: standard deviation; LR: lactate at rest; LWO: lactate without overload; L12g: lactate with 12 grams of additional load; L13.5g: lactate with 13.5 grams of additional load. 1: first evaluation; 2: final evaluation. One-factor ANOVA
p < 0.05.
Graph 1Comparison between the pre and post-training CTG lactate tests.
Graph 2Comparison between pre-versus post-training CTG.